Trump's tariff threat takes the wind out of India's pharma stocks
India currently imposes a 10% tariff on medicines imported from US. If Donald Trump decides to increase the tariff on Indian drug exports from zero to 10%, it could hit the earnings of companies like Dr Reddy's Labs and Lupin.

What's Your Reaction?






